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Summary
A variety of genetic and inhibitor studies have shown
that phosphoinositide 3-kinase  (PI3K) plays an
essential role in a number of physiological re-
sponses, including neutrophil chemotaxis, mast cell
degranulation, and cardiac function [1–6]. PI3K is
currently thought to be composed of a p110 catalytic
subunit and a single regulatory subunit, p101. The
binding of p110 to p101 dramatically increases the
activation of the complex by G subunits and,
hence, is thought to be critical for the coupling of
PI3K to G protein coupled receptors [7–9]. Here, we
characterize a new regulatory subunit for PI3K. p84
is present in human, mouse, chicken, frog, and fugu
genomes and is located beside the p101 locus. It is
broadly expressed in cells of the murine immune sys-
tem. Both recombinant and endogenous p84 bind
p110 specifically and with high affinity. Binding of
p84 to p110 substantially increases the ability of
G to stimulate phosphatidylinositol (3,4,5)-tris-
phosphate (PtdIns(3,4,5)P3) production both in vitro
and in vivo. However, the p84/p110 heterodimer is
approximately 4-fold less sensitive to Gs than
p101/p110. Endogenous murine p84 expression is
substantially reduced in the absence of p110 expres-
sion. We conclude that p110 has two potential regu-
latory subunits in vivo, p84 and p101.
Results and Discussion
Cloning and Expression of Mouse p84
The program BLAST was used to search for sequence
similarity to the mouse p101 sequence in the mouse
EST nucleotide sequences present in the EMBL data-
base. Significant hits for sequences, other than the true
p101, were used to scan the Ensembl database (release
6.33b.1) with the program SSAHA. We identified a ge-
nomic region stretched over 50 kb of the chromosome
11 just downstream of the p101 gene. This gene has
been highly conserved during evolution as it is found in
fugu, chicken, mouse, and human; and interestingly, in
all cases, it is immediately downstream of the p101 lo-
cus (Figure 1A and Figure S1 available with this article
online). We found evidence of a single gene related
similarly to both p84 and p101 in the ciona genome.*Correspondence: len.stephens@bbsrc.ac.ukAlthough we can not exclude the possibility that there
is a second related gene in ciona, it appears that a gene
duplication event occurred subsequent to the diver-
gence of the vertebrates. The coding sequence of the
murine gene is arranged into 20 exons, and the iden-
tified amino acid sequence shared 30% identity and
37% similarity with p101, mainly in the C- and N-ter-
minal ends (see Figure S2). The full mouse protein se-
quence was 752 amino acids long with an estimated
molecular mass of 84,276 Da. Thus far, we have failed
to identify any recognized domains within its structure.
We have studied p84 mRNA expression by analyzing
human multiple-tissue Northern blots with a probe gen-
erated from 525 bp of the human coding sequence. The
Northern blots revealed a band of approximately 4 Kb,
which was a little higher than the 3.2 Kb expected size
of full-length p84 mRNA (see Figure S3). These blots
showed that the mRNA was expressed mainly in leuko-
cytes, bone marrow, spleen, and lymph node and less
in fetal liver, placenta, and small intestine. Another
band of about 2 Kb was found in heart and skeletal
muscle, revealing a possible splice variant (see Figure
S3). By screening EST databases, we found three ESTs
that suggest possible mouse variants. One would form
either a very short peptide or an N-terminal truncation
of about 30 amino acids (identified EST by201034). The
other two change the reading frame and lead to prema-
ture termination after 500 to 600 amino acids (55–65
KDa, bb556657 and bb617125).
The same immune tissue blots were also hybridised
with p101- or p110γ-directed probes (see Figure S3).
The p101 mRNAs were expressed at high level in leuko-
cytes and much less in spleen, lymph node, thymus,
and bone marrow. The p110γ expression was similar in
all immune tissues screened. These results show that
p84, like p101 and p110γ, is mostly expressed in cells
from the haematopoeitic compartment.
We then performed Western blots within mouse im-
mune tissues with a rabbit anti-p84 antiserum raised
against full-length, recombinant, Sf9-derived, (EE)-tag-
ged p84 (murine sequence). The antiserum was
affinity purified with full-length, recombinant, bacteri-
ally-derived, (HIS)-tagged p84 (murine sequence). Im-
munoblots with this antibody preparation decorated a
protein with an apparent size of approximately 84 KDa,
which was found expressed at similar levels in murine
macrophages, bone marrow, and neutrophil cytosolic
fractions. Its level was lower in the cytosolic fractions
prepared from thymus and lymph node. Interestingly,
the level of p84 in cytosolic fractions derived from neu-
trophils from p110γ knockout (p110γ−/−) mice was re-
duced to about 10% of that in wild-type mouse neutro-
phils (Figure 1B).
Reprobing the same blots with an affinity-purified,
sheep, anti-p101 antiserum revealed that p101 was ex-
pressed at the same level in thymus, lymph node, neu-
trophils, and bone marrow. Its expression was reduced
in macrophages and neutrophils from p110γ−/− mice.
Similarly, reprobing these filters with a rabbit anti-p110γ
antiserum revealed a doublet, of approximately 120
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567Figure 1. Characterization of p84
(A) Radial tree showing the phylogenetic relationship of p84 and p101. This was created from the CLUSTALX alignment with the PHYLIP
programs, PROTDIST, FITCH, and DRAWTREE. A single sequence was found in the current Ciona database. Sequence identity could not
determine with which of the paralogs it was homologous.
(B) Tissue distribution of p84 within the murine immune system. Western blots were performed on cytosol fractions of different mouse immune
tissues. The same immune blots were used for immunoblotting with anti-p84, anti-p101, anti-p110γ, and anti-β-cop antibodies (loading
control). Similar results were obtained in one further experiment.KDa, that was equivalently expressed in neutrophils,
bone marrow, and macrophages and less in thymus
and lymph node (Figure 1B).
These results demonstrate that the expression of
both p84 and p101 is dependent on p110γ. They also
highlight the problems in interpreting the molecular ori-
gins of the interesting phenotype of p110γ−/− mice as
these animals are also substantially deficient in p101
and p84. The recent development of p110γ kinase-
dead, knockin (PI3KKD/KD) mice, which should not have
altered p101 nor p84 expression, has revealed that
many features of the p110γ−/− phenotype are the result
of loss of p110γ catalytic activity, and hence, the conse-
quences of partial deficiencies in p101 and p84 must be
small or they substantially manifest via p110γ. However,
analysis of PI3KKD/KD mice has shown they do not pre-
sent the same aspects of the cardiac phenotype of
p110γ−/− mice. Evidence was presented that shows that
this discrepancy may result from p110γ acting as a
scaffold for a complex containing phosphodiesterase
3B (PDE3B) [10]. Our results indicate it is also possible
these p110γ:PDE3B interactions could be via p84 and/
or p101.
Regulation of p110 by p84 In Vitro
To address questions about the effect of p84 on the
kinase activity of p110γ, we cloned it into a mammalian-
expression vector downstream of, and in frame with, an
(EE) epitope tag and cotransfected it into COS-7 cells
with (Myc)-p110γ (Figure 2). We used (EE)-p101 as a
positive control. The transfected cells were lysed and
the lysates immunoprecipitated with anti-(EE) monoclo-
nal antibody covalently coupled to protein G-Sephar-ose beads. After immunoprecipitation, (Myc)-p110γ
was only recovered from the beads when coexpressed
either with p84 or p101, demonstrating a specific, tight
interaction between p84 and p110γ. Immunoblotting
with an anti-(EE) antibody revealed p101 and p84 were
similarly expressed in these experiments. The anti-(EE)
immunoprecipitates prepared in these experiments
were eluted and assayed for PI3K activity; only when
p110γ was associated with p84 could we detect Gβγ-
stimulated PI3K activity (Figure 2B).
To more fully characterize the catalytic properties of
the p84/p110γ heterodimer, we prepared parallel prepa-
rations of (EE)-p84/p110γ and (EE)-p101/p110γ by anti-
(EE) immunoprecipitation from lysates of relevantly
infected Sf9 cells. The protein preparations were sub-
stantially pure showing that interactions between p84
and p110γ were direct and the near stoichiometric re-
covery of p110γ confirmed the high affinity of their in-
teraction. PI3K assays were performed on these pro-
teins and revealed p84/p110γ heterodimers, although
substantially activated by Gβ1γ2, were approximately
four times less sensitive to Gβ1γ2 than p101/p110γ (Fig-
ure 2C).
Regulation of p110 by p84 In Vivo
To investigate the regulation of p84/p110γ in vivo, we
cotransfected COS-7 cells with various combinations
of expression vectors encoding for (EE)-p84, (Myc)-
p110γ, (EE)-p101, (EE)-Gβ1, and (Myc)-Gγ2. After label-
ing the cells with [32P]-Pi, phosphoinositides were ex-
tracted, deacylated, and separated by HPLC (Figure
3A). These experiments showed the presence of p84
augmented PtdIns(3,4)P and PtdIns(3,4,5)P accumu-2 3
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568Figure 2. p84 Binds to and Activates p110γ In Vitro
(A) Interaction of p84 and p110γ in vitro. (EE)-p84 and (Myc)-p110γ were transfected individually or together into COS-7 cells. p101 and p110γ
were used as a positive control. Lane 1, (EE)-p84; lane 2, (Myc)-p110γ; lane 3, (EE)-p84 + (Myc)-p110γ; lane 4, (EE)-p101 + (Myc)-p110γ. The
cells lysates were then immunoprecipitated with anti-(EE) beads. Samples of the total input protein (cell lysates) and the pellets resulting
from the immunoprecipitation were immunoblotted either with anti-(Myc) (top) or anti-(EE) antibody preparations (bottom).
(B) PI3K assays performed on proteins eluted from the anti-(EE)-immunoprecipitates. The immunoprecipitated and eluted protein fractions
were incubated with liposomes containing PtdIns(4,5)P2 in the presence or absence of Gβγ and [γ32P]-ATP. [32P]-labeled phosphoinositide
products were extracted, deacylated, and resolved on TLC plates. The data shown here are a representative experiment of three and are
presented as the means (n = 3, ± SE) from a densitometric analysis of primary autoradiographs.
(C) Characterization of Gβγ activation of p84/p110γ. The PI3K activity of p84/p110γ or p101/p110γ was determined in the presence of a range
of Gβ1γ2 concentrations. The data presented are means Dpms (n = 3 ± SE).lation in the presence of p110γ and Gβ1γ2. The extent a
pof augmentation by p84 was significantly less than that
with p101. Western blots were performed to assess the i
iquantity of the (EE)-proteins expressed in the experi-
ments and revealed a similar expression of (EE)-p84
and (EE)-p101 (Figure 3B). C
WWe further tested whether endogenous p84 could in-
teract with endogenous p110γ in mouse neutrophils. e
wUsing anti-p84 antiserum, we immunoprecipitated the
endogenous p84 from neutrophil cytosolic fractions o
pand performed kinase assays with liposomes contain-
ing PtdIns(4,5)P2 and [γ32P]-ATP (Figure 4A). For con- p
dtrols, we performed immunoprecipitations with a pre-
immune antiserum (from the animal that generated p
ethe anti-p84 antibody) and an anti-p101 antiserum and
also used cytosolic fractions from the neutrophils of t
wp110γ−/− mice.
We could specifically immunoprecipitate PI3K activ- l
ity from murine neutrophil cytosol fractions with anti-
p84-antiserum (Figure 4B). Parallel immunoprecipi- b
stations from matched cytosolic fractions, prepared
from p110γ−/− murine neutrophils, failed to specifically A
simmunoprecipitate any PI3K activity (i.e., the activity
detected was the same as the preimmune control). This s
hsuggests endogenous p84 is associated with a PI3K
activity that is due to p110γ. Examination of the relative e
cextents of immunoprecipitation of p84, p101, and p110γnd comparison of the PI3K activity that (via their de-
letion from the cytosolic fractions) appeared in these
mmunoprecipitates suggests the major p110γ adaptor
n murine neutrophils is p101.
onclusions
e previously cloned and characterized p101, the hith-
rto only known regulatory subunit of p110γ [7]. Here,
e present data describing a second regulatory subunit
f p110γ, p84. Both regulatory subunits are mainly ex-
ressed in cells of haematopoietic origin. Based on its
rimary structure p84 has low homology with p101. In-
eed, only 30% identity was found between the two
roteins, mainly in the N- and C-terminal ends. How-
ver, previous work in our laboratory showed that these
wo areas were important for the interaction of p101
ith p110γ and that the N terminus of p101 was abso-
utely required for the Gβγ activation of p110γ [11].
In this report, we have demonstrated that p84 can
ind to p110γ in vitro and in vivo and by doing so sub-
tantially augmented the activation of p110γ by Gβγs.
t present, we can only speculate about the possible
ignificance of there being two potential regulatory
ubunits for p110γ. The fact that both p84 and p101
ave been faithfully conserved and yet can be found
xpressed in the same cell types suggests that they
ontribute significantly different properties to p110γ
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569Figure 3. p84 Binds to p110γ In Vivo
(A) In vivo activation of (EE)-p84/(Myc)-p110γ
by Gβγ. COS-7 cells were transfected with
expression vectors containing the indicated
cDNAs. 40 hr posttransfection, the cells
were serum starved for 6 hr then labeled with
[32P]-Pi for 90 min. Phosphoinositides were
extracted, deacylated, and resolved by
HPLC and quantified by scintillation count-
ing. The data presented are means (n = 3 or
4, ± range, pooled from two independent ex-
periments) and were normalised via the
[32P]-PtdIns(4)P produced during the assay.
(B) Western blots of total cell lysates (from
replicate dishes of cells to those which were
[32P]-Pi-labeled) with anti-(EE) antibodies,
showing expression levels of (EE)-p84, (EE)-
p101, and (EE)-Gβ1.heterodimers. Precedent in the signaling field indicates
this sort of diversity underpins additional specific sig-
naling connections. For example, by providing a dif-
ferent membrane-targeting address, PtdIns(3,4,5)P3
might be produced in a distinct compartment; changed
membrane association could also enable different ki-
netics of activation of PtdIns(3,4,5)P3 accumulation, or
alternatively, a different pattern of sensitivity to Gβγ
species might enable coupling to other receptors.
Because PI3Kγ is also regulated by Ras-GTPases,
further investigations should assess the effect of p84
on p110γ activity in the presence of GTP-Ras [12]. It
also remains to be determined which of the many im-
portant physiological roles of p110γ depend on p101
and which on p84.
Supplemental Data
Supplemental Data include three figures and Supplemental Experi-
mental Procedures and can be found with this article online at
http://www.current-biology.com/cgi/content/full/15/6/566/DC1/.
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